Pancreatic adenocarcinoma response to chemotherapy enhanced with non-invasive radio frequency evaluated via an integrated experimental/computational approach

Abstract Although chemotherapy combined with radiofrequency exposure has shown promise in cancer treatment by coupling drug cytotoxicity with thermal ablation or thermally-induced cytotoxicity, limited access of the drug to tumor loci in hypo-vascularized lesions has hampered clinical application. W...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Matthew J. Ware, Louis T. Curtis, Min Wu, Jason C. Ho, Stuart J. Corr, Steven A. Curley, Biana Godin, Hermann B. Frieboes
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2017
Materias:
R
Q
Acceso en línea:https://doaj.org/article/c728934e59a64e6d824b05df0ba3d5db
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:c728934e59a64e6d824b05df0ba3d5db
record_format dspace
spelling oai:doaj.org-article:c728934e59a64e6d824b05df0ba3d5db2021-12-02T11:40:50ZPancreatic adenocarcinoma response to chemotherapy enhanced with non-invasive radio frequency evaluated via an integrated experimental/computational approach10.1038/s41598-017-03040-02045-2322https://doaj.org/article/c728934e59a64e6d824b05df0ba3d5db2017-06-01T00:00:00Zhttps://doi.org/10.1038/s41598-017-03040-0https://doaj.org/toc/2045-2322Abstract Although chemotherapy combined with radiofrequency exposure has shown promise in cancer treatment by coupling drug cytotoxicity with thermal ablation or thermally-induced cytotoxicity, limited access of the drug to tumor loci in hypo-vascularized lesions has hampered clinical application. We recently showed that high-intensity short-wave capacitively coupled radiofrequency (RF) electric-fields may reach inaccessible targets in vivo. This non-invasive RF combined with gemcitabine (Gem) chemotherapy enhanced drug uptake and effect in pancreatic adenocarcinoma (PDAC), notorious for having poor response and limited therapeutic options, but without inducing thermal injury. We hypothesize that the enhanced cytotoxicity derives from RF-facilitated drug transport in the tumor microenvironment. We propose an integrated experimental/computational approach to evaluate chemotherapeutic response combined with RF-induced phenotypic changes in tissue with impaired transport. Results show that RF facilitates diffusive transport in 3D cell cultures representing hypo-vascularized lesions, enhancing drug uptake and effect. Computational modeling evaluates drug vascular extravasation and diffusive transport as key RF-modulated parameters, with transport being dominant. Assessment of hypothetical schedules following current clinical protocol for Stage-IV PDAC suggests that unresponsive lesions may be growth-restrained when exposed to Gem plus RF. Comparison of these projections to experiments in vivo indicates that synergy may result from RF-induced cell phenotypic changes enhancing drug transport and cytotoxicity, thus providing a potential baseline for clinically-focused evaluation.Matthew J. WareLouis T. CurtisMin WuJason C. HoStuart J. CorrSteven A. CurleyBiana GodinHermann B. FrieboesNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 7, Iss 1, Pp 1-13 (2017)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Matthew J. Ware
Louis T. Curtis
Min Wu
Jason C. Ho
Stuart J. Corr
Steven A. Curley
Biana Godin
Hermann B. Frieboes
Pancreatic adenocarcinoma response to chemotherapy enhanced with non-invasive radio frequency evaluated via an integrated experimental/computational approach
description Abstract Although chemotherapy combined with radiofrequency exposure has shown promise in cancer treatment by coupling drug cytotoxicity with thermal ablation or thermally-induced cytotoxicity, limited access of the drug to tumor loci in hypo-vascularized lesions has hampered clinical application. We recently showed that high-intensity short-wave capacitively coupled radiofrequency (RF) electric-fields may reach inaccessible targets in vivo. This non-invasive RF combined with gemcitabine (Gem) chemotherapy enhanced drug uptake and effect in pancreatic adenocarcinoma (PDAC), notorious for having poor response and limited therapeutic options, but without inducing thermal injury. We hypothesize that the enhanced cytotoxicity derives from RF-facilitated drug transport in the tumor microenvironment. We propose an integrated experimental/computational approach to evaluate chemotherapeutic response combined with RF-induced phenotypic changes in tissue with impaired transport. Results show that RF facilitates diffusive transport in 3D cell cultures representing hypo-vascularized lesions, enhancing drug uptake and effect. Computational modeling evaluates drug vascular extravasation and diffusive transport as key RF-modulated parameters, with transport being dominant. Assessment of hypothetical schedules following current clinical protocol for Stage-IV PDAC suggests that unresponsive lesions may be growth-restrained when exposed to Gem plus RF. Comparison of these projections to experiments in vivo indicates that synergy may result from RF-induced cell phenotypic changes enhancing drug transport and cytotoxicity, thus providing a potential baseline for clinically-focused evaluation.
format article
author Matthew J. Ware
Louis T. Curtis
Min Wu
Jason C. Ho
Stuart J. Corr
Steven A. Curley
Biana Godin
Hermann B. Frieboes
author_facet Matthew J. Ware
Louis T. Curtis
Min Wu
Jason C. Ho
Stuart J. Corr
Steven A. Curley
Biana Godin
Hermann B. Frieboes
author_sort Matthew J. Ware
title Pancreatic adenocarcinoma response to chemotherapy enhanced with non-invasive radio frequency evaluated via an integrated experimental/computational approach
title_short Pancreatic adenocarcinoma response to chemotherapy enhanced with non-invasive radio frequency evaluated via an integrated experimental/computational approach
title_full Pancreatic adenocarcinoma response to chemotherapy enhanced with non-invasive radio frequency evaluated via an integrated experimental/computational approach
title_fullStr Pancreatic adenocarcinoma response to chemotherapy enhanced with non-invasive radio frequency evaluated via an integrated experimental/computational approach
title_full_unstemmed Pancreatic adenocarcinoma response to chemotherapy enhanced with non-invasive radio frequency evaluated via an integrated experimental/computational approach
title_sort pancreatic adenocarcinoma response to chemotherapy enhanced with non-invasive radio frequency evaluated via an integrated experimental/computational approach
publisher Nature Portfolio
publishDate 2017
url https://doaj.org/article/c728934e59a64e6d824b05df0ba3d5db
work_keys_str_mv AT matthewjware pancreaticadenocarcinomaresponsetochemotherapyenhancedwithnoninvasiveradiofrequencyevaluatedviaanintegratedexperimentalcomputationalapproach
AT louistcurtis pancreaticadenocarcinomaresponsetochemotherapyenhancedwithnoninvasiveradiofrequencyevaluatedviaanintegratedexperimentalcomputationalapproach
AT minwu pancreaticadenocarcinomaresponsetochemotherapyenhancedwithnoninvasiveradiofrequencyevaluatedviaanintegratedexperimentalcomputationalapproach
AT jasoncho pancreaticadenocarcinomaresponsetochemotherapyenhancedwithnoninvasiveradiofrequencyevaluatedviaanintegratedexperimentalcomputationalapproach
AT stuartjcorr pancreaticadenocarcinomaresponsetochemotherapyenhancedwithnoninvasiveradiofrequencyevaluatedviaanintegratedexperimentalcomputationalapproach
AT stevenacurley pancreaticadenocarcinomaresponsetochemotherapyenhancedwithnoninvasiveradiofrequencyevaluatedviaanintegratedexperimentalcomputationalapproach
AT bianagodin pancreaticadenocarcinomaresponsetochemotherapyenhancedwithnoninvasiveradiofrequencyevaluatedviaanintegratedexperimentalcomputationalapproach
AT hermannbfrieboes pancreaticadenocarcinomaresponsetochemotherapyenhancedwithnoninvasiveradiofrequencyevaluatedviaanintegratedexperimentalcomputationalapproach
_version_ 1718395544337907712